Company page
Icure Pharmaceutical Incorporation
Icure Pharmaceutical Incorporation, traded under the ticker 175250, operates in the Korean market with a current market capitalization of approximately 52.26 million USD. The company focuses on developing innovative pharmaceutical solutions. Investors can find relevant information about its operations and performance on its public company page.
- Ticker
- 175250:KRX
- Asset type
- Stock
- Market cap
- $52.3M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- KRX
- Currency
- KRW